CLEPSO 2014 meeting - Keynote Speakers

YRobert BROWN, Imperial College London, UK

Pharmacoepigenomics of ovarian cancer


Graham BURDGE, University of Southampton, Southampton, UK

Epigenetics: implications for personalised nutrition


Hyang-Min BYUN, Harvard School of Public Health, Boston, USA

Epigenetic changes through airborne pollutants


Norbert GATTERMANN, University of Düsseldorf, Germany

Epigenetic Treatment of MDS


Clarissa GERHÄUSER, German Cancer Research Center (DKFZ), Heidelberg, Germany

Nutrition Epigenetics 


Carlos GUERRERO-BOSAGNA, Linköping, Sweden 

Environmental Exposures and Epigenetic Transgenerational Effects on Fertility 


Per GULDBERG, Danish Cancer Society Research Center, Copenhagen, Denmark

Epigenetics of Melanoma


Cecile HAUMAITRE, French Institute of Health and Medical Research (INSERM), Paris, France

Epigenetic regulation of pancreatic islets


Jiri HEJNAR, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Prospects to epigenetic treatment of HIV infection


Elisabeth HEßMANN, University of Marburg, Germany

Epigenetics of Pancreatic Cancer


Albert JELTSCH, University of Stuttgart, Stuttgart, Germany

DNA methylation patterns revisited – how they look like and how they are maintained


Yutaka KONDO, Aichi Cancer Center Research Institute, Nagoya, Japan

Epigenetic Alterations in Human Hepatocarcinogenesis


Charlotte LING, Lund University Diabetes Centre, Malmö, Sweden

Epigenetics in Diabetes


Philipp LIRK, University of Amsterdam, The Netherlands

Lidocaine as a hypomethylating agent in breast cancer


Richard MOMPARLER, University of Montreal, Canada

Epigenetic therapy of non-small cell lung cancer using decitabine


Antoinette S. PERRY, Trinity College Dublin, Ireland

Translational Epigenomics for the early detection of Aggressive Prostate Cancer


Jan POSTBERG, Helios Medical Center Wuppertal, Germany 

Biological relevance of the testis-specific histone variant H3.5 and implication in disease


Marianne ROTS, University Medical Center Groningen, The Netherlands

Epigenetic Editing: an innovative strategy to mimic and reverse epi-mutations in breast cancer


Richard SAFFERY, Murdoch Children’s Research Institute, Melbourne, Australia

Timing and tissue-specific alterations of the early life human epigenome in response to in utero environmental exposures.


Luca SIGALOTTI, Centro di Riferimento Oncologico, Aviano, Italy

Methylation Changes in Malignant Melanoma


Norman C.W. WONG, University of Calgary, Canada

Epigenetics of Atherosclerosis


Matthias ZILBAUER, University of Cambridge, United Kingdom

Epigenetics in inflammatory bowel disease


Vlatka ZOLDOS, University of Zagreb, Zagreb, Croatia

Epigenetics of protein glycosylation and its implications in human diseases